Palmitic acid-rich oils with and without interesterification lower postprandial lipemia and increase atherogenic lipoproteins compared with a MUFA-rich oil: A randomized controlled trial

Am J Clin Nutr. 2021 May 8;113(5):1221-1231. doi: 10.1093/ajcn/nqaa413.

Abstract

Background: Interesterified (IE) fats are widely used in place of trans fats; however, little is known about their metabolism.

Objectives: To test the impact of a commonly consumed IE compared with a non-IE equivalent fat on in vivo postprandial and in vitro lipid metabolism, compared with a reference oil [rapeseed oil (RO)].

Methods: A double-blinded, 3-phase crossover, randomized controlled trial was performed in healthy adults (n = 20) aged 45-75 y. Postprandial plasma triacylglycerol and lipoprotein responses (including stable isotope tracing) to a test meal (50 g fat) were evaluated over 8 h. The test fats were IE 80:20 palm stearin/palm kernel fat, an identical non-IE fat, and RO (control). In vitro, mechanisms of digestion were explored using a dynamic gastric model (DGM).

Results: Plasma triacylglycerol 8-h incremental area under the curves were lower following non-IE compared with RO [-1.7 mmol/L⋅h (95% CI: -3.3, -0.0)], but there were no differences between IE and RO or IE and non-IE. LDL particles were smaller following IE and non-IE compared with RO (P = 0.005). Extra extra large, extra large, and large VLDL particle concentrations were higher following IE and non-IE compared with RO at 6-8 h (P < 0.05). No differences in the appearance of [13C]palmitic acid in plasma triacylglycerol were observed between IE and non-IE fats. DGM revealed differences in phase separation of the IE and non-IE meals and delayed release of SFAs compared with RO.

Conclusions: Interesterification did not modify fat digestion, postprandial lipemia, or lipid metabolism measured by stable isotope and DGM analysis. Despite the lower lipemia following the SFA-rich fats, increased proatherogenic large triacylglycerol-rich lipoprotein remnant and small LDL particles following the SFA-rich fats relative to RO adds a new postprandial dimension to the mechanistic evidence linking SFAs to cardiovascular disease risk.

Keywords: healthy adults; interesterification; lipid; metabolism; palmitic acid; postprandial lipemia; rapeseed oil.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Apolipoprotein B-48
  • Atherosclerosis / chemically induced
  • Chylomicrons / chemistry
  • Cross-Over Studies
  • Dietary Fats, Unsaturated / administration & dosage
  • Dietary Fats, Unsaturated / adverse effects*
  • Dietary Fats, Unsaturated / analysis*
  • Double-Blind Method
  • Fatty Acids, Monounsaturated / administration & dosage
  • Fatty Acids, Monounsaturated / adverse effects*
  • Female
  • Humans
  • Hyperlipidemias / chemically induced
  • Lipoproteins / blood*
  • Male
  • Middle Aged
  • Palmitic Acid / administration & dosage
  • Palmitic Acid / adverse effects*
  • Palmitic Acid / chemistry
  • Postprandial Period*
  • Triglycerides

Substances

  • Apolipoprotein B-48
  • Chylomicrons
  • Dietary Fats, Unsaturated
  • Fatty Acids, Monounsaturated
  • Lipoproteins
  • Triglycerides
  • Palmitic Acid